NCT00608907 2012-01-30An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)Millennium Pharmaceuticals, Inc.Phase 1 Completed61 enrolled 9 charts